PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Citius Pharmaceuticals, Inc.
Filed: April 18, 2025
Period of Report: April 18, 2025
Accession Number: 0001213900-25-033368

View Document ↗ View on SEC.gov ↗